FluoGuide A/S, a biotech company maximizing surgical outcomes in oncology by lighting up cancer, today announced positive results from the first part of its ongoing FG001-CT-005 Phase 2 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results